(Christoph Burgstedt/iStock/Getty Images Plus) The RNA world hypothesis posits that molecules made up of ribonucleic acids ...

Scientists have identified a new RNA molecule that may play a key role in improving survival in cancer patients.

Spearheaded by patient-scientist Sonia Vallabh and Eric Minikel at the Broad Institute, a new drug candidate designed to slow the progression of prion disease is entering a phase 1 clinical trial, ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced the ...

Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying ...

RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.

Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how ...

RNA epigenetics also called Epitranscriptomics is an evolving field of research that explores chemical modifications on RNA and their impact on the cell and ...

A strand of RNA just 45 nucleotides long can copy its own complementary sequence in frozen conditions that may resemble early ...